National manufacturer of
immunobiological products in Russia


  • Perm scientists presented «Diphage» - innovational complex product to treat nosocomial infections

    Perm scientists presented their project of producing innovational complex prouct "Diphage", based on Acinetobacter baumannii and Pseudomonas aeruginosa
    Read more
  • In Moscow Microgen announced results of first year of using a unique Russian A-type botulinum toxin «Relatox®» in aesthetic medicine

    Opinion leaders of «Relatox®» presented the results of using Russian A-type botulinum toxin at the latest regional practice conference in Moscow.
    Read more
  • Seasonal vaccination against flu using new «Sovigripp» vaccine has started in Russia

    The Ministry of Health and the Federal Service on Surveillance for consumer rights protection and human well-being (Rospotrebnadzor) announced that more than 5.5 million people in 82 regions were vaccinated
    Read more
  • Microbiologists form NGO Microgen patented a novel symptom-modifying drug product which has no analogues on the Russian market.

    The Ufa branch of NGO Microgen developed a unique technology of effective post-treatment of an aqueous solution of the active substance of a symptom-modifying drug product Chondrolon-Pro
    Read more
  • NGO Microgen implemented a unique system of quality and efficiency control of each dose of the tick-borne encephalitis vaccine

    To determine the level of the main component (tick-borne encephalitis virus antigen), which determines the effectiveness of the vaccine, Russian specialists have developed and implemented an original method for assaying the antigen in the sample using ELISA and specialized computer analysis. 
    Read more
  • Clinical trials of two new Russian-made pentavalent vaccines were stated

    According to specialists of this company, one of the main benefits of the novel combination vaccines is the lack of a preservative containing organic compounds of mercury, thimerosal.
    Read more